Real World Observational Database for COVID-19 Treatment and Outcomes
Latest Information Update: 06 Sep 2024
At a glance
- Drugs Tocilizumab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 02 Sep 2024 Status changed from active, no longer recruiting to completed.
- 11 May 2022 Planned End Date changed from 1 Mar 2022 to 1 Mar 2023.
- 11 May 2022 Status changed from recruiting to active, no longer recruiting.